...
首页> 外文期刊>Protein and Peptide Letters >Characterization of Rhodamine Conjugated Agiotensin II Peptide: Synthesis, Analysis and Receptor Binding and Internalization.
【24h】

Characterization of Rhodamine Conjugated Agiotensin II Peptide: Synthesis, Analysis and Receptor Binding and Internalization.

机译:罗丹明缀合的血管紧张素II肽的表征:合成,分析和受体结合与内化。

获取原文
获取原文并翻译 | 示例
           

摘要

HP (2-20) (AKKVFKRLEKLFSKIQNDK) is the antibacterial sequence derived from N-terminus of Helicobacter pylori Ribosomal Protein L1 (RPL1). It has a broad-spectrum microbicidal activity in vitro that is thought to be related to the membrane-disruptive properties of the peptide. Based on the putative membrane-targeted mode of action, we postulated that HP (2-20) might be possessed virus-cell fusion inhibitory activity. To develop the novel virus-cell fusion inhibitory peptides, several analogues with amino acid substitution were designed to increase or decrease only net hydrophobic region. In particular, substitution of Gln and Asp for hydrophobic amino acid, Trp at position 17 and 19 of HP (2-20) (Anal 3) caused a dramatic increase in virus-cell fusion inhibitory activity without hemolytic effect.
机译:HP(2-20)(AKKVFKRLEKLFSKIQNDK)是源自幽门螺杆菌核糖体蛋白L1(RPL1)N端的抗菌序列。它在体外具有广谱杀微生物活性,被认为与该肽的膜破坏特性有关。基于假定的膜靶向作用方式,我们推测HP(2-20)可能具有病毒细胞融合抑制活性。为了开发新的病毒-细胞融合抑制肽,设计了几种具有氨基酸取代的类似物以仅增加或减少净疏水区。尤其是,用Gln和Asp取代了HP(2-20)(氨基酸3)的位置17和19上的疏水氨基酸Trp引起病毒细胞融合抑制活性的急剧增加,而没有溶血作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号